These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1851593)

  • 1. A human TSH-secreting adenoma: endocrine, biochemical and morphological studies. Evidence of somatostatin receptors by using quantitative autoradiography. Clinical and biological improvement by SMS 201-995 treatment.
    Polak M; Bertherat J; Li JY; Kujas M; Le Dafniet M; Weizani H; Van Effenterre R; Epelbaum J; Turpin G
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):479-86. PubMed ID: 1851593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
    J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of a GH- and TSH-secreting pituitary adenoma to a somatostatin analogue (SMS 201-995): evidence that GH and TSH coexist in the same cell and secretory granules.
    Malarkey WB; Kovacs K; O'Dorisio TM
    Neuroendocrinology; 1989 Mar; 49(3):267-74. PubMed ID: 2716953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A; Sanno N; Tahara S; Osamura YR
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).
    Lee EJ; Kim KR; Lim SK; Lee HC; Kim DI; Kim SH; Huh KB
    Eur J Endocrinol; 1994 Jul; 131(1):109-12. PubMed ID: 8038902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of SMS 201-995, a long-acting somatostatin analogue, on the secretion and morphology of a pituitary growth hormone cell adenoma.
    George SR; Kovacs K; Asa SL; Horvath E; Cross EG; Burrow GN
    Clin Endocrinol (Oxf); 1987 Apr; 26(4):395-405. PubMed ID: 2888549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
    Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995).
    Warnet A; Lajeunie E; Gelbert F; Duet M; Chanson P; Cophignon J; Harris AG
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):487-91. PubMed ID: 2031445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and morphological features of undifferentiated monomorphous GH/TSH-secreting pituitary adenoma.
    Skorić T; Korsić M; Zarković K; Plavsić V; Besenski N; Breskovac L; Giljević Z; Paladino J
    Eur J Endocrinol; 1999 Jun; 140(6):528-37. PubMed ID: 10366409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas.
    Colao A; Merola B; Ferone D; Marzullo P; Cerbone G; Longobardi S; Di Somma C; Lombardi G
    Eur J Endocrinol; 1995 Aug; 133(2):189-94. PubMed ID: 7655643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas.
    Gancel A; Vuillermet P; Legrand A; Catus F; Thomas F; Kuhn JM
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):421-8. PubMed ID: 8187308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional thyrotropin- and growth hormone-secreting pituitary adenoma with a ultrastructurally monomorphic feature: a case study.
    Ozawa Y; Kameya T; Kasuga A; Naritaka H; Kanda N; Maruyama H; Saruta T
    Endocr J; 1998 Apr; 45(2):211-9. PubMed ID: 9700474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
    Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone (TRH) binding sites and thyrotropin response to TRH are regulated by thyroid hormones in human thyrotropic adenomas.
    Le Dafniet M; Brandi AM; Kujas M; Chanson P; Peillon F
    Eur J Endocrinol; 1994 Jun; 130(6):559-64. PubMed ID: 8205254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of thyrotropin-secreting pituitary adenomas with octreotide.
    Shimatsu A; Murabe H; Kamoi K; Suzuki Y; Nakao K
    Endocr J; 1999 Feb; 46(1):113-23. PubMed ID: 10426575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of receptors for thyrotropin (TSH)-releasing hormone in human TSH-secreting pituitary adenomas associated with hyperthyroidism.
    Chanson P; Li JY; Le Dafniet M; Derome P; Kujas M; Murat A; Charpentier G; Racadot J; Peillon F
    J Clin Endocrinol Metab; 1988 Feb; 66(2):447-50. PubMed ID: 2828411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a long-acting somatostatin analogue (SMS 201-995) on a growth hormone and thyroid stimulating hormone-producing pituitary tumor.
    Hirasawa R; Hashimoto K; Makino S; Suemaru S; Takao T; Ota Z; Hoshida Y; Yoshino T; Akagi T
    Acta Med Okayama; 1991 Apr; 45(2):107-15. PubMed ID: 1867112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSH producing pituitary tumor: biochemical diagnosis and long-term medical management with octreotide.
    Chayen SD; Gross D; Makhoul O; Glaser B
    Horm Metab Res; 1992 Jan; 24(1):34-8. PubMed ID: 1612557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy.
    Blackhurst G; Strachan MW; Collie D; Gregor A; Statham PF; Seckl JE
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):401-4. PubMed ID: 12201834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.